mitoxantrone has been researched along with Jaw Diseases in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Jaw Diseases: Diseases involving the JAW.
Excerpt | Relevance | Reference |
---|---|---|
"The case of a 58-year-old female with breast cancer who developed multiple and ultimately fatal metastases despite 3 years of treatment with chemotherapeutic drugs and intravenous bisphosphonates, is presented herein." | 5.43 | Mitoxantrone as a contributing factor in medication-related osteonecrosis of the jaws. ( Bagan, JV; Bagan, L; Poveda, R; Scully, C, 2016) |
"The case of a 58-year-old female with breast cancer who developed multiple and ultimately fatal metastases despite 3 years of treatment with chemotherapeutic drugs and intravenous bisphosphonates, is presented herein." | 1.43 | Mitoxantrone as a contributing factor in medication-related osteonecrosis of the jaws. ( Bagan, JV; Bagan, L; Poveda, R; Scully, C, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bagan, JV | 1 |
Bagan, L | 1 |
Poveda, R | 1 |
Scully, C | 1 |
1 other study available for mitoxantrone and Jaw Diseases
Article | Year |
---|---|
Mitoxantrone as a contributing factor in medication-related osteonecrosis of the jaws.
Topics: Antineoplastic Agents; Breast Neoplasms; Fatal Outcome; Female; Humans; Jaw Diseases; Middle Aged; M | 2016 |